Our study reveals that BRAF, H3F3A and IDH1 mutations are associated with distinct clinical features and can stratify young adult glioblastomas into prognostic subgroups, which have important clinical implications in refining the prognostic classification of glioblastomas in young adults. The gene discussed is IDH1; the disease is glioblastoma.